Jared Gardner provides a detailed microscopic overview of Synovial Sarcoma (SS), a translocation-associated soft tissue tumor most commonly found deep in the extremities (often near the knee) in young adults. The video first explores the classic, less common Biphasic SS, which features two distinct components: epithelial cells forming nests or glands, and uniform, hypercellular blue spindle cells. It then covers the more frequent Monophasic SS, focusing on the diagnostic uniform spindle cell morphology, arranged in streaming fascicles (sometimes a herringbone pattern), and the common presence of branching "staghorn" vessels. Dr. Gardner emphasizes that the tumor's translocation etiology (SS18/SSX fusion resulting from t(X;18)) leads to a crucial histological feature: a lack of nuclear pleomorphism, even in malignant areas. The video discusses key immunohistochemical markers (EMA, Cytokeratin, TLE1, CD34 negativity) and highlights the aggressive Poorly Differentiated SS variant, characterized by sheets of large round cells, high mitotic activity, and necrosis. A key educational takeaway stressed throughout is that the tumor name is a historical misnomer, as SS does not arise from synovial cells.
A Detailed Histopathological Review of Synovial Sarcoma
0:03 Introduction & Biphasic SS Definition: Synovial Sarcoma (SS) is a deep soft tissue entity, not usually dermatopathology. The video starts with the classic, but less common, Biphasic SS, defined by two distinct components.
0:37 Biphasic Components (Epithelial): The epithelial component consists of epithelioid cells with abundant cytoplasm, arranged in nests and trabeculae. On closer inspection (1:41), these structures form glands (lumens) filled with pink debris or mucin, mimicking a glandular neoplasm.
1:00 Biphasic Components (Spindle Cell): The stroma is filled with uniform, dark blue, hypercellular spindle cells, often compared to the appearance of endometrial stroma.
2:29 The No-Pleomorphism Rule: Crucially, SS spindle cells, despite being hypercellular and having high mitotic rates, lack nuclear pleomorphism. This is a hallmark of translocation-associated sarcomas (vs. aneuploid tumors which show pleomorphism).
4:09 Molecular Translocation: SS is defined by the t(X;18) translocation, leading to the fusion of the SS18 gene (formerly SYT) with partner genes SSX1 or SSX2 (rarely SSX4).
Epithelial Markers: EMA (Epithelial Membrane Antigen) and Pan Cytokeratin are highly useful and sensitive, staining the epithelial component strongly and the spindle component patchily.
TLE1: Relatively sensitive, but not specific. Caution is advised as TLE1 can also stain solitary fibrous tumor (SFT) and malignant peripheral nerve sheath tumor (MPNST).
CD34: Almost universally negative (useful for differentiating from SFT).
S100: Can be patchy positive in a significant subset of SS.
8:56 Monophasic Synovial Sarcoma (MSS): This is the more common form, lacking the glandular component. Histology is sheets of uniform blue spindle cells with mitotic activity but no pleomorphism.
9:21 Vascular Pattern: MSS often features dilated, branching, "staghorn" vessels, a feature shared with SFT, making differentiation challenging without ancillary studies.
10:16 Fascicular Growth: Spindle cells run in streaming fascicles, sometimes intersecting at sharp angles, creating a Herringbone pattern.
11:10 Myxoid Change and Mimics: SS can exhibit myxoid (bluish) change, leading to hypocellular areas where spindle cells are stretched in strands. These hypocellular areas (13:05) can look deceptively benign or resemble neural tumors (like neurofibroma).
14:04 Ropy Collagen: Another common feature shared with SFT is the presence of thick, ropy collagen bundles.
16:15 Clinical Context: SS usually occurs in the extremities, especially near the knee. It is most common in young adults (10β40 years old).
17:09 Crucial Takeaway (Nomenclature): The name "Synovial Sarcoma" is misleading; these tumors are not associated with, and do not arise from, synovium or joints.
18:30 Calcification: Calcifications are a common feature, occurring in about a third of cases, sometimes accompanied by metaplastic bone formation.
21:40 Poorly Differentiated Synovial Sarcoma (PDS): This aggressive variant shows sheets of large round cells or large epithelioid cells, characterized by high mitotic activity and geographic zones of necrosis.
28:31 Prognostic Significance of PDS: If greater than 20% of the tumor contains a PDS component, it predicts a worse prognosis and more aggressive behavior.
31:53 PDS Subtype: PDS can present as a "small round blue cell tumor" pattern, which must be differentiated from other entities like Ewing's sarcoma. (32:23) Caution is advised regarding CD99 use, as it is highly nonspecific.
33:33 Final Confirmation: SS is a mesenchymal tumor (sarcoma), confirmed by its molecular translocation, even though it expresses epithelial markers (keratin, EMA).